120 related articles for article (PubMed ID: 37096502)
1. [Correlation between
Zhang LF; Ma Y; Li L; Liu WE; Zhang XC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):333-337. PubMed ID: 37096502
[TBL] [Abstract][Full Text] [Related]
2. Association of two ARID5B gene variant single nucleotide polymorphisms with acute lymphoblastic leukemia in the Egyptian population.
Gamaleldin MA; Imbaby SAE
Asian Pac J Cancer Prev; 2023 Jan; 24(1):337-343. PubMed ID: 36708585
[TBL] [Abstract][Full Text] [Related]
3. Association of relapse-linked ARID5B single nucleotide polymorphisms with drug resistance in B-cell precursor acute lymphoblastic leukemia cell lines.
Tamai M; Huang M; Kagami K; Abe M; Somazu S; Shinohara T; Harama D; Watanabe A; Akahane K; Goi K; Sugita K; Goto H; Minegishi M; Iwamoto S; Inukai T
Cancer Cell Int; 2020 Sep; 20(1):434. PubMed ID: 33499894
[TBL] [Abstract][Full Text] [Related]
4. Association of ARID5B gene variants with acute lymphoblastic leukemia in Yemeni children.
Al-Absi B; Noor SM; Saif-Ali R; Salem SD; Ahmed RH; Razif MF; Muniandy S
Tumour Biol; 2017 Apr; 39(4):1010428317697573. PubMed ID: 28381164
[TBL] [Abstract][Full Text] [Related]
5. Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia.
Csordas K; Lautner-Csorba O; Semsei AF; Harnos A; Hegyi M; Erdelyi DJ; Eipel OT; Szalai C; Kovacs GT
Br J Haematol; 2014 Aug; 166(3):410-20. PubMed ID: 24712521
[TBL] [Abstract][Full Text] [Related]
6.
Mosaad YM; Khashaba M; Darwish A; Darwish M; Elwassefy M; Abdelmabood S; Fawzy IM; Youssef LF; Elbasiouny RA
Pediatr Hematol Oncol; 2019 Sep; 36(6):365-375. PubMed ID: 31424309
[No Abstract] [Full Text] [Related]
7. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.
Xu H; Cheng C; Devidas M; Pei D; Fan Y; Yang W; Neale G; Scheet P; Burchard EG; Torgerson DG; Eng C; Dean M; Antillon F; Winick NJ; Martin PL; Willman CL; Camitta BM; Reaman GH; Carroll WL; Loh M; Evans WE; Pui CH; Hunger SP; Relling MV; Yang JJ
J Clin Oncol; 2012 Mar; 30(7):751-7. PubMed ID: 22291082
[TBL] [Abstract][Full Text] [Related]
8. [SLCO1B1c. 521T>C gene polymorphisms are associated with high-dose methotrexate pharmacokinetics and clinical outcome of pediatric acute lymphoblastic leukemia].
Zhang H; He X; Li J; Wang Y; Wang C; Chen Y; Niu C; Gao P
Zhonghua Er Ke Za Zhi; 2014 Oct; 52(10):770-6. PubMed ID: 25537545
[TBL] [Abstract][Full Text] [Related]
9. Variants in ARID5B gene are associated with the development of acute lymphoblastic leukemia in Mexican children.
Reyes-León A; Ramírez-Martínez M; Fernández-García D; Amaro-Muñoz D; Velázquez-Aragón JA; Salas-Labadía C; Zapata-Tarrés M; Velasco-Hidalgo L; López-Santiago N; López-Ruiz MI; Malavar-Guadarrama MA; Cárdenas-Cardós R; Paredes-Aguilera R; Rivera-Luna R; Dean M; Pérez-Vera P
Ann Hematol; 2019 Oct; 98(10):2379-2388. PubMed ID: 31227872
[TBL] [Abstract][Full Text] [Related]
10.
Al-Zayan NR; Ashour MJ; Abuwarda HN; Sharif FA
Pediatr Hematol Oncol; 2024; 41(2):103-113. PubMed ID: 37578068
[TBL] [Abstract][Full Text] [Related]
11. Association of Genetic Variants in ARID5B, IKZF1 and CEBPE with Risk of Childhood de novo B-Lineage Acute Lymphoblastic Leukemia in India.
Bhandari P; Ahmad F; Mandava S; Das BR
Asian Pac J Cancer Prev; 2016; 17(8):3989-95. PubMed ID: 27644650
[TBL] [Abstract][Full Text] [Related]
12. Association of
Razali RH; Noorizhab MNF; Jamari H; James RJ; Teh KH; Ibrahim HM; Teh LK; Salleh MZ
Pediatr Hematol Oncol; 2020 Apr; 37(3):185-197. PubMed ID: 31870219
[TBL] [Abstract][Full Text] [Related]
13. ARID5B, CEBPE and PIP4K2A Germline Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia in Mexican Patients: A MIGICCL Study.
Bekker-Méndez VC; Núñez-Enríquez JC; Torres Escalante JL; Alvarez-Olmos E; González-Montalvoc PM; Jiménez-Hernández E; Sansón AM; Leal YA; Ramos-Cervantes MT; Guerra-Castillo FX; Ortiz-Maganda MP; Flores-Lujano J; Pérez-Saldivar ML; Velazquez-Aviña MM; Bolea-Murga V; Torres-Nava JR; Amador-Sanchez R; Solis-Labastida KA; Rámirez-Bello J; Fragoso JM; Mejía-Aranguré JM;
Arch Med Res; 2016 Nov; 47(8):623-628. PubMed ID: 28476190
[TBL] [Abstract][Full Text] [Related]
14. Contributions of ARID5B, IKZF1, PIP4K2A, and GATA3 Gene Polymorphisms to Childhood Acute Lymphoblastic Leukemia in a Chinese Population.
Liu X; Xiao M; Xing Z; Jiang H; Zhu C; Zhang X; Li W; Wang Z; Wu F; Chen Y
J Pediatr Hematol Oncol; 2023 Apr; 45(3):123-129. PubMed ID: 36952466
[TBL] [Abstract][Full Text] [Related]
15. ARID5B polymorphism confers an increased risk to acquire specific MLL rearrangements in early childhood leukemia.
Emerenciano M; Barbosa TC; Lopes BA; Blunck CB; Faro A; Andrade C; Meyer C; Marschalek R; Pombo-de-Oliveira MS;
BMC Cancer; 2014 Feb; 14():127. PubMed ID: 24564228
[TBL] [Abstract][Full Text] [Related]
16.
Xu H; Zhao X; Bhojwani D; E S; Goodings C; Zhang H; Seibel NL; Yang W; Li C; Carroll WL; Evans WE; Yang JJ
Clin Cancer Res; 2020 Jan; 26(1):256-264. PubMed ID: 31573954
[TBL] [Abstract][Full Text] [Related]
17. High-resolution melting analyses for genetic variants in ARID5B and IKZF1 with childhood acute lymphoblastic leukemia susceptibility loci in Taiwan.
Lin CY; Li MJ; Chang JG; Liu SC; Weng T; Wu KH; Yang SF; Huang FK; Lo WY; Peng CT
Blood Cells Mol Dis; 2014; 52(2-3):140-5. PubMed ID: 24200646
[TBL] [Abstract][Full Text] [Related]
18.
Mosaad YM; Hammad A; AlHarrass MF; Sallam R; Shouma A; Hammad E; Ahmed EO; Abdel-Azeem HA; Sherif D; Fawzy I; Elbahnasawy A; Abdel Twab H
Lupus; 2021 Jul; 30(8):1226-1232. PubMed ID: 33888010
[TBL] [Abstract][Full Text] [Related]
19. Effects of splicing-regulatory polymorphisms in ABCC2, ABCG2, and ABCB1 on methotrexate exposure in Chinese children with acute lymphoblastic leukemia.
Li M; Kong XY; Wang SM
Cancer Chemother Pharmacol; 2023 Jan; 91(1):77-87. PubMed ID: 36463535
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism in
Zhang YX; Ma Y; Zhang H; Zhang WP; Yang XY
Int J Clin Pharmacol Ther; 2020 May; 58(5):254-260. PubMed ID: 32053102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
